Basal Cell Carcinoma Treatment Market

Basal cell carcinoma (BCC) is the most common type of skin cancer. It?s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC.

Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo).

Basal Cell Carcinoma Treatment Market contains market size and forecasts of Basal Cell Carcinoma Treatment in Global, including the following market information:

Global Basal Cell Carcinoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Basal Cell Carcinoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Basal Cell Carcinoma Treatment include Roche, Sun Pharmaceuticals, Bausch Health Companies, Taro Pharmaceuticals and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Basal Cell Carcinoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Basal Cell Carcinoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, by Type, 2021 (%)

Topical Treatment

Hedgehog Pathway Inhibitor Therapy

Mohs Surgery

Other Surgeries

Other Treatments

Global Basal Cell Carcinoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, by Application, 2021 (%)

Hospitals

Specialty Clinics

Others

Global Basal Cell Carcinoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Basal Cell Carcinoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Basal Cell Carcinoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Basal Cell Carcinoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Sun Pharmaceuticals

Bausch Health Companies

Taro Pharmaceuticals

Mylan